7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 
      
    		                          
      operating activities
    		                          
      net income
    		-77,645,000 -110,993,000 -92,731,000 -16,819,000 46,690,000 46,264,000 54,941,000 26,669,000 8,476,000 499,000 -48,932,000 -54,631,000 -48,313,000 -30,409,000 -41,739,000 -50,450,000 -57,318,000 -82,871,000 -19,002,000 -24,531,000 -29,874,000 -19,222,000 -28,408,000 -35,505,000 -51,889,000 -25,977,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                          
      depreciation and amortization
    		60,411,000 56,423,000 50,101,000 48,915,000 46,247,000 42,689,000 36,866,000 33,788,000 29,775,000 26,409,000 23,623,000 19,476,000 17,805,000 16,341,000 16,661,000 14,522,000 12,770,000 11,955,000 10,967,000 10,107,000 9,419,000 8,202,000 7,003,000 5,830,000 5,320,000 4,873,000 
      amortization of intangible assets
    		7,627,000 7,634,000 7,339,000 6,333,000 6,337,000 5,995,000 5,503,000 4,637,000 4,102,000 4,174,000 4,227,000 4,146,000 4,104,000 4,088,000 3,830,000 3,337,000 3,318,000 2,417,000 869,000 372,000 104,000 103,000 102,000 100,000 139,000 146,000 
      amortization of deferred contract acquisition costs
    		107,038,000 102,903,000 91,124,000 79,862,000 73,723,000 74,128,000 65,743,000 60,281,000 57,555,000 55,322,000 49,258,000 43,996,000 39,962,000 37,592,000 34,172,000 29,293,000 26,043,000 24,376,000 21,485,000 16,769,000 14,720,000 13,451,000 11,334,000 9,049,000 7,731,000 7,345,000 
      non-cash operating lease cost
    		4,531,000 4,186,000 4,183,000 3,933,000 3,795,000 3,372,000 3,673,000 3,394,000 3,239,000 3,092,000 2,622,000 2,294,000 2,287,000 2,237,000 2,376,000 2,258,000 2,289,000 2,180,000 120,000 2,727,000 2,656,000 2,283,000     
      stock-based compensation expense
    		287,153,000 253,604,000 272,531,000 208,888,000 200,877,000 183,125,000 176,272,000 159,614,000 164,777,000 130,856,000 152,347,000 140,113,000 131,550,000 102,494,000 92,637,000 86,666,000 76,287,000 54,362,000 47,714,000 40,610,000 37,713,000 23,638,000 24,363,000 21,966,000 29,859,000 3,752,000 
      deferred income taxes
    		-639,000 -1,681,000 -7,781,000 -193,000 -1,674,000 -255,000 -1,032,000 -2,003,000 -97,000 -255,000 -980,000 682,000 -148,000 1,752,000             
      realized gains on strategic investments
    		  -94,000 0 654,000 -6,881,000                     
      non-cash interest expense
    		1,205,000 1,088,000 1,015,000 963,000 911,000 874,000 836,000 806,000 777,000 754,000 736,000 711,000 697,000 669,000 645,000 625,000 604,000 595,000 347,000 186,000 169,000 151,000 142,000 130,000   
      change in fair value of strategic investments
    		0 1,579,000         2,927,000 -629,000 -1,920,000 -2,208,000 -467,000 0 0 -4,356,000         
      accretion of short-term investments purchased at a discount
    		  0 0 0 2,285,000 -351,000                    
      changes in operating assets and liabilities, net of impact of acquisitions
    		                          
      accounts receivable
    		-77,863,000 319,871,000 -313,403,000 -152,876,000 41,811,000 150,249,000 -283,557,000 -20,860,000 -78,371,000 165,089,000 -140,869,000 -66,512,000 -49,670,000 -1,058,000 -84,710,000 -16,387,000 -55,723,000 31,466,000 -66,323,000 -22,175,000 -4,631,000 20,651,000 -19,436,000 -30,829,000 -28,177,000 5,375,000 
      deferred contract acquisition costs
    		-148,819,000 -102,803,000 -223,072,000 -203,079,000 -91,853,000 -66,480,000 -164,971,000 -84,671,000 -72,475,000 -49,532,000 -115,451,000 -74,325,000 -57,586,000 -51,354,000 -82,407,000 -64,325,000 -51,176,000 -36,400,000 -66,234,000 -35,753,000 -26,425,000 -22,563,000 -31,356,000 -27,450,000 -19,317,000 -8,471,000 
      prepaid expenses and other assets
    		-29,416,000 -20,995,000 -147,400,000 20,392,000 -34,622,000 -28,602,000 -80,548,000 4,366,000 -17,796,000 -8,542,000 -32,686,000 -3,183,000 -15,181,000 4,243,000 -19,747,000 38,095,000 -47,114,000 -769,000 -284,000 3,440,000 -7,285,000 5,332,000 -23,584,000 -7,378,000 -8,456,000 -4,049,000 
      accounts payable
    		69,918,000 -83,228,000 50,843,000 34,168,000 -348,000 276,000 -21,259,000 5,343,000 15,614,000 -18,596,000 -40,470,000 24,213,000 37,225,000 -36,431,000 40,281,000 -12,416,000 15,945,000 -10,562,000 4,769,000 -3,078,000 4,898,000 4,736,000 -2,797,000 2,124,000 -8,715,000 2,818,000 
      accrued expenses and other liabilities
    		56,479,000 -43,763,000 132,851,000 77,699,000 24,597,000 -16,629,000 -19,011,000 28,662,000 41,511,000 -36,576,000 37,103,000 16,097,000 13,023,000 -7,300,000             
      accrued payroll and benefits
    		12,917,000 -37,848,000 -4,023,000 119,328,000 -11,740,000 -17,692,000 63,292,000 31,971,000 -12,880,000 -17,281,000 43,591,000 21,390,000 -12,990,000 13,235,000 10,423,000 -595,000 16,884,000 5,969,000 14,500,000 19,423,000 -1,359,000 648,000 -95,000 16,848,000 7,374,000 -6,601,000 
      operating lease liabilities
    		-3,527,000 -4,586,000 -3,845,000 -4,699,000 -2,582,000 -4,531,000 2,112,000 -9,672,000 -3,276,000 -3,199,000 -3,327,000 -2,333,000 -2,494,000 -2,210,000 -2,506,000 -2,372,000 -2,467,000 -2,555,000 -6,671,000 -2,749,000 4,290,000 -2,975,000     
      deferred revenue
    		63,462,000 42,716,000 527,084,000 103,321,000 23,818,000 15,041,000 510,984,000 33,127,000 103,850,000 48,678,000 339,574,000 171,346,000 151,555,000 163,276,000 240,826,000 123,840,000 142,366,000 109,376,000 149,221,000 70,910,000 53,867,000 64,805,000 123,529,000 77,877,000 54,550,000 24,812,000 
      net cash from operating activities
    		332,832,000 384,107,000 345,722,000 326,136,000 326,641,000 383,228,000 347,016,000 273,518,000 244,781,000 300,892,000 273,293,000 242,851,000 209,906,000 214,957,000 159,718,000 159,058,000 108,475,000 147,533,000 114,463,000 88,501,000 55,025,000 98,577,000 66,107,000 38,635,000 -6,214,000 1,415,000 
      capex
    		-47,786,000 -103,188,000 -104,914,000 -94,975,000 -53,770,000 -60,162,000 -63,436,000 -33,894,000 -55,490,000 -73,166,000 -63,766,000 -68,774,000 -74,149,000 -57,425,000 -26,723,000 -35,555,000 -34,836,000 -30,230,000 -17,073,000 -12,406,000 -22,608,000 -11,576,000 -15,431,000 -31,587,000 -22,944,000 -17,525,000 
      free cash flows
    		285,046,000 280,919,000 240,808,000 231,161,000 272,871,000 323,066,000 283,580,000 239,624,000 189,291,000 227,726,000 209,527,000 174,077,000 135,757,000 157,532,000 132,995,000 123,503,000 73,639,000 117,303,000 97,390,000 76,095,000 32,417,000 87,001,000 50,676,000 7,048,000 -29,158,000 -16,110,000 
      investing activities
    		                          
      purchases of property and equipment
    		-30,497,000 -85,751,000 -87,211,000 -78,704,000 -39,254,000 -49,683,000 -52,584,000 -21,264,000 -40,417,000 -62,264,000 -55,410,000 -61,270,000 -66,128,000 -52,211,000 -26,723,000 -29,627,000 -29,997,000 -25,796,000 -12,554,000 -9,911,000 -20,640,000 -9,694,000 -13,350,000 -29,689,000 -21,618,000 -15,541,000 
      capitalized internal-use software and website development costs
    		-17,289,000 -17,437,000 -17,703,000 -16,271,000 -14,516,000 -10,479,000 -10,852,000 -12,630,000 -15,073,000 -10,902,000 -8,356,000 -7,504,000 -8,021,000 -5,214,000             
      purchases of strategic investments
    		-1,043,000 -374,000 -7,000,000 -10,000,000 -1,044,000 -1,658,000 -5,000,000 0 -1,664,000 -10,513,000                 
      proceeds from sales of strategic investments
    		1,242,000 3,146,000 1,612,000 0 488,000 10,407,000                     
      business acquisitions, net of cash acquired
    		  -213,876,000 0 -5,000 -96,376,000 -281,000    115,000    -60,772,000            
      proceeds from maturities and sales of short-term investments
    		  0 0 0 97,300,000 98,281,000 0                   
      purchases of deferred compensation investments
    		-1,311,000 -1,459,000 -906,000 -606,000 -600,000 -609,000 -569,000 -586,000 -586,000 -290,000                 
      proceeds from sales of deferred compensation investments
    		119,000 45,000  0                       
      net cash from investing activities
    		-48,779,000 -101,830,000 -325,019,000 -105,581,000 -54,890,000 -51,098,000 20,395,000 -468,836,000 41,760,000 66,031,000 -319,140,000 -97,419,000 -79,149,000 -60,950,000 -93,660,000 -44,735,000 -41,175,000 -384,946,000 -17,301,000 -98,375,000 -23,608,000 634,711,000 -572,115,000 -27,262,000 -34,392,000 4,138,000 
      financing activities
    		                          
      proceeds from the issuance of common stock upon exercise stock options
    		1,721,000 634,000  844,000 1,641,000 823,000                     
      proceeds from issuance of common stock under the employee stock purchase plan
    		  43,517,000 0   30,943,000 0   24,974,000 0   22,825,000 0   16,979,000 0       
      distributions to non-controlling interest holders
    		  -806,000 0 -244,000 -3,841,000                     
      capital contributions from non-controlling interest holders
    		0 1,500,000 3,000,000 0 5,000,000 500,000 0 0 2,831,000 5,257,000 1,901,000 5,090,000 2,501,000 1,462,000 250,000 4,250,000 3,000,000 655,000 0 250,000 50,000 500,000     
      net cash from financing activities
    		74,187,000 2,134,000 46,386,000 844,000 62,496,000 -2,518,000 33,460,000 2,053,000 49,737,000 7,908,000 29,134,000 4,976,000 38,759,000 4,568,000 26,178,000 7,554,000 36,190,000 2,609,000 760,529,000 5,171,000 27,542,000 6,893,000 27,310,000 -968,000 680,684,000 -882,000 
      effect of foreign exchange rates on cash, cash equivalents and restricted cash
    		49,000 6,546,000 -4,637,000 399,000 877,000 -1,917,000 5,369,000 -4,494,000 1,273,000 -190,000 5,579,000 -2,744,000               
      net increase in cash, cash equivalents and restricted cash
    		358,289,000 290,957,000 62,452,000 221,798,000 335,124,000 327,695,000 406,240,000 -197,759,000 337,551,000 374,641,000 -11,134,000 147,664,000               
      cash, cash equivalents and restricted cash at beginning of period
    		0 4,324,666,000 0 0 0 3,377,597,000 0 0 0 2,456,924,000 0 0               
      cash, cash equivalents and restricted cash at end of period
    		358,289,000 4,615,623,000 62,452,000 221,798,000 335,124,000 3,705,292,000 406,240,000 -197,759,000 337,551,000 2,831,565,000 -11,134,000 147,664,000               
      cash, cash equivalents and restricted cash at the end of period:
    		                          
      cash and cash equivalents
    		358,283,000 4,614,153,000 62,971,000 221,788,000 336,099,000 3,702,437,000 406,197,000 -198,343,000 337,538,000 2,829,677,000 -11,182,000 147,693,000               
      restricted cash included in prepaid expenses and other assets
    		6,000 1,470,000 -519,000 10,000 -975,000 2,855,000 43,000 584,000 13,000 1,888,000 48,000 -29,000               
      total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows
    		358,289,000 4,615,623,000  221,798,000 335,124,000 3,705,292,000  -197,759,000 337,551,000 2,831,565,000  147,664,000               
      supplemental disclosure of cash flow information:
    		                          
      interest paid
    		0 11,250,000 0 11,250,000 0 11,250,000 0 11,250,000 0 11,250,000 4,000 11,258,000 24,000 11,265,000 40,000 157,000 67,000 11,000 14,000    4,000 1,000 1,000 1,000 
      income taxes paid, net of refunds received
    		9,005,000 17,026,000 4,827,000 3,945,000 2,656,000 7,594,000 4,697,000 7,920,000 6,614,000 3,377,000 5,174,000 1,802,000 1,019,000 3,948,000 70,823,000 1,517,000 952,000 1,385,000 169,000 900,000       
      supplemental disclosure of non-cash investing and financing activities:
    		                          
      net increase in property and equipment included in accounts payable and accrued expenses
    		  -13,359,000    2,785,000 14,223,000 2,390,000 -22,479,000 9,150,000 -5,539,000 5,645,000 13,165,000 -544,000 2,586,000 186,000 4,294,000 -3,713,000 5,775,000 -297,000 -723,000 -2,478,000 -4,535,000   
      equity consideration for acquisitions
    		  687,000 0 0 468,000 0    0    0 0 0 4,011,000 0        
      operating lease liabilities arising from obtaining operating right-of-use assets
    		   4,155,000 1,095,000 1,759,000                     
      proceeds from sales of strategic investments not yet received
    		-1,185,000 1,846,000 184,000 0 74,000 4,734,000                     
      stock-based compensation included in capitalized software development costs and fixed assets
    		15,140,000 13,291,000 5,025,000 12,456,000 11,512,000 7,966,000                     
      noncash consideration for the purchase of strategic investments
    		  0 0 0 3,319,000                     
      noncash consideration received from sales of strategic investments
    		  0 0 0 3,319,000                     
      net decrease in property and equipment included in accounts payable and accrued expenses
    		 -32,212,000   1,186,000 -17,655,000                     
      purchases of intangible assets
    		      -10,600,000 -26,000                   
      purchases of short-term investments
    		      0                    
      proceeds from the sale of deferred compensation investments
    		                          
      repayment of loan payable
    		          0                
      proceeds from issuance of common stock upon exercise of stock options
    		      2,517,000 2,053,000 1,474,000 2,651,000 2,259,000 1,477,000 1,813,000 3,106,000 3,103,000 3,304,000 5,738,000 3,754,000 7,309,000 4,921,000 10,208,000 6,393,000 12,162,000 824,000 7,016,000 1,510,000 
      total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows
    		                          
      vesting of early exercised stock options
    		          0 734,000 735,000 735,000 776,000 795,000 797,000 797,000 797,000 799,000 849,000 873,000     
      operating lease liabilities arising from obtaining operating right of-use assets
    		        -764,000 13,847,000 16,762,000 -428,000   276,000 1,470,000 530,000 2,591,000         
      purchases of intangible assets included in accrued expenses and other liabilities
    		        -474,000 500,000                 
      payments of debt issuance costs related to revolving line of credit
    		                          
      payments of debt issuance costs related to senior notes
    		                          
      proceeds from sales of investments
    		         150,000,000                 
      gain on sale of debt securities
    		                   0 0 -1,347,000     
      amortization of marketable securities purchased at a premium
    		                          
      purchases of investments
    		                          
      maturities of marketable securities
    		                  0 0 0 91,605,000 31,212,000 74,450,000 54,319,000 68,995,000 
      proceeds from issuance of senior notes, net of debt financing costs
    		                          
      debt financing costs, accrued but not paid
    		                          
      purchase of strategic investments
    		           -10,181,000 -5,000,000 -2,825,000  -8,500,000 -6,000,000 -1,309,000 0 -500,000       
      purchase of intangible assets
    		           0 0 -700,000             
      payment of debt issuance costs related to revolving line of credit
    		               0 0 -219,000         
      payment of debt issuance costs related to senior notes
    		               0 0 -1,581,000         
      effect of foreign exchange rates on cash and cash equivalents
    		             -2,472,000 -3,111,000 -1,420,000 -1,436,000 1,193,000 991,000 -105,000 784,000 12,000 -109,000 392,000 -263,000 -86,000 
      net increase in cash and cash equivalents
    		             156,103,000 89,125,000 120,457,000 102,054,000 -233,611,000 858,682,000 -4,808,000 59,743,000 740,193,000 -478,807,000 10,797,000 639,815,000 4,585,000 
      cash and cash equivalents, beginning of period
    		             1,996,633,000 0 0 0 1,918,608,000 0 0 0 264,798,000 0 0 0 88,408,000 
      cash and cash equivalents, end of period
    		             2,152,736,000 89,125,000 120,457,000 102,054,000 1,684,997,000 858,682,000 -4,808,000 59,743,000 1,004,991,000 -478,807,000 10,797,000 639,815,000 92,993,000 
      change in fair value of redeemable convertible preferred stock warrant liability
    		                      0 0 4,855,000 1,167,000 
      amortization
    		                          
      other non-cash charges
    		                          
      purchases of marketable securities
    		                  0 0 0 -84,904,000 -592,004,000 -70,125,000 -65,767,000 -51,805,000 
      proceeds from sales of marketable securities
    		                  0 0 0 639,586,000 5,108,000 0 0 4,473,000 
      proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts
    		                      0 0   
      payments of deferred offering costs
    		                      0 -1,792,000 -1,688,000 -2,392,000 
      proceeds from the issuance of common stock upon exercise of early exercisable stock options
    		                      0 0   
      settlement related to stockholder short-swing trade profit
    		                          
      conversion of redeemable convertible preferred stock to common stock
    		                      0 -101,295,000   
      conversion of redeemable convertible preferred stock warrant liabilities reclassified to additional paid-in capital
    		                      0 0   
      net decrease in deferred offering costs, accrued but not paid
    		                          
      loss on disposal of property and equipment
    		               15,000           
      accrued expenses and other current liabilities
    		               26,584,000 26,013,000 29,229,000 22,195,000 9,755,000 -7,017,000 -1,095,000 5,768,000 5,500,000 312,000 -2,407,000 
      other liabilities, noncurrent
    		                      -240,000 335,000 -216,000 -177,000 
      capitalized internal-use software and website development
    		               -5,928,000 -4,839,000 -4,434,000         
      benefit from credit losses
    		                          
      accretion of marketable securities purchased at a premium
    		                          
      changes in operating assets and liabilities, net of impact of acquisition
    		                          
      other liabilities
    		                -551,000 12,828,000 871,000 2,667,000 4,198,000 1,052,000     
      business acquisition, net of cash acquired
    		                -339,000 -353,407,000 -48,000        
      loss on disposal of fixed assets
    		                 19,000         
      benefit from bad debts
    		                 274,000 -96,000 -179,000 -418,000 149,000     
      changes in operating assets and liabilities
    		                          
      gain on debt and equity securities
    		                          
      accretion
    		                          
      capitalized internal-use software
    		                  -4,519,000 -2,495,000 -1,968,000 -1,882,000 -2,081,000 -1,898,000 -1,326,000 -1,984,000 
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		                          
      proceeds from revolving line of credit
    		                          
      issuance costs related to revolving line of credit
    		                          
      repayment of revolving line of credit
    		                          
      repayment of notes receivable from related parties
    		                          
      payments of contingent consideration
    		                          
      payments of indemnity holdback
    		                          
      repurchase of stock options
    		                          
      contingent consideration associated with business combinations
    		                          
      net increase in deferred offering costs, accrued but not paid
    		                      0    
      accretion (amortization) of marketable securities purchased at a discount
    		                   0       
      amortization (accretion) of marketable securities purchased at a discount
    		                     578,000     
      income taxes paid
    		                     353,000 808,000 641,000 299,000 114,000 
      accretion of marketable securities purchased at a discount
    		                      66,000 -353,000 -447,000 -513,000 
      changes in operating assets and liabilities, net of business combinations
    		                          
      business combinations, net of cash acquired
    		                          
      acquisition of intangible assets
    		                          
      issuance of notes receivable to related parties
    		                          
      indemnity holdback consideration associated with business combinations
    		                          
      accretion of redeemable convertible preferred stock
    		                          
      allowance for doubtful accounts
    		                       391,000 276,000 -254,000 
      proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs
    		                          
      ​
    		                          
      other
    		                         -424,000 
      net change in deferred offering costs, accrued but not paid
    		                         -1,210,000 
      net change in property and equipment included in accounts payable and accrued expenses
    		                         -54,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.